Fluvastatin Sodium Patent Expiration

Fluvastatin Sodium was first introduced by Novartis Pharmaceuticals Corp in its drug Lescol on Dec 31, 1993. Another drug containing Fluvastatin Sodium is Lescol Xl. 7 different companies have introduced drugs containing Fluvastatin Sodium.


Fluvastatin Sodium Patents

Given below is the list of patents protecting Fluvastatin Sodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lescol Xl US6242003

(Pediatric)

Organic compounds Oct 13, 2020

(Expired)

Sandoz
Lescol Xl US6242003 Organic compounds Apr 13, 2020

(Expired)

Sandoz



Fluvastatin Sodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fluvastatin Sodium Generic API Manufacturers

Several generic applications have been filed for Fluvastatin Sodium. The first generic version for Fluvastatin Sodium was by Mylan Pharmaceuticals Inc. and was approved on Apr 11, 2012. And the latest generic version is by Beijing Sciecure Pharmaceutical Co Ltd and was approved on Apr 26, 2021.

Given below is the list of companies who have filed for Fluvastatin Sodium generic, along with the locations of their manufacturing plants worldwide.